Content about Specialty pharmacy

August 17, 2010

A drug used to treat narcolepsy soon could win approval to treat the chronic pain...

August 15, 2010

The Food and Drug Administration has approved a prefilled dual-chamber syringe made by Pfizer for...

NEW YORK The Food and Drug Administration has approved a prefilled dual-chamber syringe made by Pfizer for treating hemophilia, Pfizer said.

 

The FDA approved the syringe for administering the drug Xyntha (antihemophilic factor [recombinant]) for hemophilia A. The drug is used to prevent and control bleeding episodes in patients.

 

 

August 12, 2010

Emergent BioSolutions will acquire Trubion Pharmaceuticals for $96.8 million upfront, under a deal the two...

August 12, 2010

The companies working on more than half of the mental illness drugs under development are...

WASHINGTON The companies working on more than half of the mental illness drugs under development are clustered in four U.S. states, according to research by the largest lobby for the drug industry.

 

The Pharmaceutical Research and Manufacturers of America compiled a study showing that of the 313 drugs, 192 are under development by companies in New York, New Jersey, North Carolina and California. The drugs are in clinical trials or under review by the Food and Drug Administration, PhRMA said.

 

 

August 11, 2010

A Food and Drug Administration advisory committee has given a nod of approval to an...

August 11, 2010

An investigational drug made by Pharmasset for treating hepatitis C will get expedited review from...

August 10, 2010

The Food and Drug Administration is allowing kidney transplant patients to use a drug for...

August 10, 2010

The drug market for unipolar depression will get smaller over the next decade due to...

August 8, 2010

An investigational drug in late-stage clinical trials increased the cure rate in patients with hepatitis...

August 5, 2010

The Food and Drug Administration has approved a new formulation of a chemotherapy drug made...

August 4, 2010

Generex has appointed a Pfizer executive to help with its cancer and influenza vaccines program....

August 3, 2010

Pfizer had a big increase in sales and a modest increase in profits during second...

August 2, 2010

Drugstore.com on Monday announced the completion of the assets sale of its DS Pharmacy subsidiary...

August 2, 2010

Hospira had net sales of $968 million and profits of $83.5 million in second quarter...

August 2, 2010

The Food and Drug Administration has given orphan drug designation to a treatment for an...

August 2, 2010

French drug maker Sanofi-Aventis has made an offer for Genzyme, according to published reports....

August 1, 2010

The Food and Drug Administration has approved a treatment for muscle spasms and twitches....

GREENSBORO, N.C. The Food and Drug Administration has approved a treatment for muscle spasms and twitches.

 

August 1, 2010

Merck had global sales of $11.3 billion and profits of $752 million during second quarter...

August 1, 2010

The Food and Drug Administration has approved a generic injected drug made by Sagent Pharmaceuticals...

SCHAUMBURG, Ill. The Food and Drug Administration has approved a generic injected drug made by Sagent Pharmaceuticals for treating migraine attacks, Sagent said Monday.

 

The FDA approved Sagent’s sumatriptan succinate injection in the 6 mg per 0.5 milliliter strength. The drug is used to treat acute migraine attacks and cluster headache episodes.

 

 

Sumatriptan is a generic version of GlaxoSmithKline’s Imitrex. Injectable sumatriptan had $22 million in sales in 2009, according to IMS Health.

July 22, 2010

Note to the Food and Drug Administration from the chain pharmacy industry: when it comes...

ROCKVILLE, Md. Note to the Food and Drug Administration from the chain pharmacy industry: when it comes to beefing up oversight and regulation of some high-risk medications, slow and steady is the best approach.

July 21, 2010

A once-daily formulation of an HIV drug made by Boehringer Ingelheim works as well as...

July 21, 2010

An investigational treatment for HIV made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals works as...

July 20, 2010

Biosimilars may have cleared their biggest stretch of wilderness thanks to their inclusion in the...

July 20, 2010

A Food and Drug Administration advisory committee has voted to recommend limiting use of a...

July 20, 2010

Fera Pharmaceuticals has acquired rights to an investigational drug for treating a rare fungal ear...